Product Introduction
Bioactivity


英文名: M2698

描述: M2698 (MSC2363318A) 是 p70S6K、Akt1 和 Akt3 的抑制剂，IC50 为 1 nM。 M2698 显示出抗癌活性。

体外活性: M2698 (0.3 nM-50 M) dose-dependently inhibits proliferation in breast tumor cell lines (IC50s: 0.02-8.5 µM). M2698 (0.3-1 µM) induces feedback loop phosphorylation on Akt and suppresses Akt and p70S6K activity in HCC1419 and MDA-MB-453 cells. M2698 inhibits indirectly pGSK3β and pS6 with IC50s of 17 and 15 nM[1].

体内活性: Gavage administration of M2698 (10-30 mg/kg) dose-dependently inhibits the growth of tumors and increases pAkt levels in tumor tissue. M2698 (30 mg/kg) causes tumor regression. M2698 (1-20 mg/kg) inhibits S6 phosphorylation in a dose-proportional manner over time[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 112.5 mg/mL (250.1 mM)


关键字: M 2698 | M-2698 | M2698

相关产品: ML-9 | LM22B-10 | DB07107 | 3β-Methoxy-2,3-dihydrowithaferin A | Ipfencarbazone | Alphitolic acid | N-​Feruloyloctopamine | MKC-1 | 3,4,5-Tricaffeoylquinic acid | Patritumab

相关库: Antioxidant Compound Library | Drug Repurposing Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Kinase Inhibitor Library | Cytoskeletal Signaling Pathway Compound Library | Anti-Cancer Active Compound Library | Bioactive Compound Library